UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 19, 2005

PHARMA SERVICES INTERMEDIATE
HOLDING CORP.

(Exact name of registrant as specified in its charter)


Delaware	333-123250	73-1678018
(State or other jurisdiction of	(Commission File	(I.R.S. Employer
incorporation)	Number)	Identification Number)

4709 Creekstone Drive, Suite 200, Durham, North Carolina 27703-8411
(Address of principal executive offices)

(919) 998-2000
Registrant’s telephone number, including area code

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events

On August 19, 2005, Quintiles Transnational Corp., a subsidiary of Pharma Services Intermediate Holding Corp., issued a press release in accordance with Rule 135c under the Securities Act of 1933, as amended. A copy of the press release is attached hereto as Exhibit 99.01 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits


Exhibit No.		Description of Exhibit

99.01		Press release, dated August 19, 2005, of Quintiles Transnational Corp. (incorporated herein by reference to Exhibit 99.01 to the Current Report on Form 8-K of Quintiles Transnational Corp. dated August 19, 2005, as filed with the Securities and Exchange Commission on August 19, 2005)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	PHARMA SERVICES INTERMEDIATE HOLDING CORP.

	By:	/s/ Dennis B. Gillings Dennis B. Gillings Executive Chairman and Chief Executive Officer

Dated: August 19, 2005

EXHIBIT INDEX


Exhibit No.		Description of Exhibit

99.01		Press release, dated August 19, 2005, of Quintiles Transnational Corp. (incorporated herein by reference to Exhibit 99.01 to the Current Report on Form 8-K of Quintiles Transnational Corp. dated August 19, 2005, as filed with the Securities and Exchange Commission on August 19, 2005)

PHARMA SERVICES INTERMEDIATE HOLDING CORP 8-K